Mercer Global Advisors
RNTX

Mercer Global Advisors’s Rein Therapeutics RNTX Stock Holding History

Mercer Global Advisors’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46.1K Buy
35,461
+17,500
+97% +$21.7K ﹤0.01% 3128
2025
Q4 		$20.8K Buy
17,961
+7,500
+72% +$10.3K ﹤0.01% 2822
2025
Q3 		$12K Buy
+10,461
New +$13.3K ﹤0.01% 2628
2022
Q4 		– Sell
-1,005
Closed -$4K – 2005
2022
Q3 		$4K Hold
1,005
– – ﹤0.01% 1816
2022
Q2 		$5K Hold
1,005
– – ﹤0.01% 1816
2022
Q1 		$10K Sell
1,005
-100
-9% -$905 ﹤0.01% 1865
2021
Q4 		$12K Buy
1,105
+55
+5% +$851 ﹤0.01% 1794
2021
Q3 		$21K Hold
1,050
– – ﹤0.01% 1744
2021
Q2 		$26K Buy
1,050
+2
+0.2% +$50 ﹤0.01% 1658
2021
Q1 		$30K Buy
1,048
+348
+50% +$11.9K ﹤0.01% 1598
2020
Q4 		$15K Buy
+700
New +$17.5K ﹤0.01% 1342

Other funds holding RNTX

VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Mercer Global Advisors's RNTX Position: Q1 2026 in Review

Mercer Global Advisors increased its Rein Therapeutics (RNTX) stake by 97% in Q1 2026, buying an estimated $21.7K and bringing the position to 35,461 shares worth $46.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3128.

Mercer Global Advisors first reported a position in RNTX in Q4 2020 and has held it in 11 quarters since. 46 funds tracked by Wall St. Rank hold RNTX as of Q1 2026.

  • Mercer Global Advisors held 35,461 shares of Rein Therapeutics worth $46.1K as of Q1 2026.
  • Mercer Global Advisors bought 17,500 Rein Therapeutics shares in Q1 2026, an estimated $21.7K.
  • Rein Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #3128 holding.
  • Mercer Global Advisors first reported a position in Rein Therapeutics in Q4 2020 and has held it in 11 quarters since.
  • 46 funds tracked by Wall St. Rank held Rein Therapeutics as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.